CT-01 Phase IB study of IMMU-115 (humanised ANTI-CD74 antibody) targeting antigen presenting cells in patients with systemic lupus erythematosus (SLE)

Daniel J Wallace; William A Wegener; Heather Horne; David M Goldenberg

doi:10.1136/lupus-2016-000179.73

Article info

Clinical Trials

CT-01 Phase IB study of IMMU-115 (humanised ANTI-CD74 antibody) targeting antigen presenting cells in patients with systemic lupus erythematosus (SLE)

Free

Authors

Daniel J Wallace 1Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA PubMed articles Google scholar articles
William A Wegener 2Immunomedics, Inc., Morris Plains, NJ, USA PubMed articles Google scholar articles
Heather Horne 2Immunomedics, Inc., Morris Plains, NJ, USA PubMed articles Google scholar articles
David M Goldenberg 2Immunomedics, Inc., Morris Plains, NJ, USA PubMed articles Google scholar articles

Citation

Wallace DJ, Wegener WA, Horne H, et al

CT-01 Phase IB study of IMMU-115 (humanised ANTI-CD74 antibody) targeting antigen presenting cells in patients with systemic lupus erythematosus (SLE)

Lupus Science & Medicine 2016;3:doi: 10.1136/lupus-2016-000179.73

Publication history

First published August 31, 2016.

Online issue publication

September 01, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password